Hypoxia-inducible factors regulate T cell metabolism and function

Molecular Immunology

Volumn 68, Issue 2, 2015, Pages 527-535

  Phan, Anthony T ^a   Goldrath, Ananda W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Differentiation; Hypoxia inducible factor; Immunity; Metabolism; T cell

Indexed keywords

CYTOKINE; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; REACTIVE OXYGEN METABOLITE; T LYMPHOCYTE RECEPTOR; UNTRANSLATED RNA; HYPOXIA INDUCIBLE FACTOR 1;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL METABOLISM; CELLULAR IMMUNITY; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TH17 CELL; ANIMAL; CELL DIFFERENTIATION; CELL HYPOXIA; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ANIMALS; CELL DIFFERENTIATION; CELL HYPOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 84949097681     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.08.004     Document Type: Article

References (78)

1. Appelhoff R.J., Tian Y.-M., Raval R.R., Turley H., Harris A.L., Pugh C.W., Ratcliffe P.J., Gleadle J.M. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 2004, 279:38458-38465.
2. Ben-Shoshan J., Maysel-Auslender S., Mor A., Keren G., George J. Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1α. Eur. J. Immunol. 2008, 38:2412-2418.
3. Blouin C.C., Pagé E.L., Soucy G.M., Richard D.E. Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1α. Blood 2004, 103:1124-1130.
4. Bollinger T., Gies S., Naujoks J., Feldhoff L., Bollinger A., Solbach W., Rupp J. HIF-1α- and hypoxia-dependent immune responses in human CD4+CD2 5high T cells and T helper 17 cells. J. Leukoc. Biol. 2014, 96:305-312.
5. Bracken C.P., Whitelaw M.L., Peet D.J. The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses. Cell. Mol. Life Sci. CMLS 2003, 60:1376-1393.
6. Bruick R.K., McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001, 294:1337-1340.
7. Brunelle J.K., Bell E.L., Quesada N.M., Vercauteren K., Tiranti V., Zeviani M., Scarpulla R.C., Chandel N.S. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 2005, 1:409-414.
8. Bruning U., Cerone L., Neufeld Z., Fitzpatrick S.F., Cheong A., Scholz C.C., Simpson D.A., Leonard M.O., Tambuwala M.M., Cummins E.P., Taylor C.T. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1α activity during prolonged hypoxia. Mol. Cell. Biol. 2011, 31:4087-4096.
9. Caldwell C.C., Kojima H., Lukashev D., Armstrong J., Farber M., Apasov S.G., Sitkovsky M.V. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J. Immunol. 2001, 167:6140-6149.
10. Cao Y., Rathmell J.C., Macintyre A.N. Metabolic reprogramming towards aerobic glycolysis correlates with greater proliferative ability and resistance to metabolic inhibition in CD8 versus CD4 T cells. PLoS One 2014, 9:e104104.
11. Chandel N.S., Maltepe E., Goldwasser E., Mathieu C.E., Simon M.C., Schumacker P.T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:11715-11720.
12. 2 sensing. J. Biol. Chem. 2000, 275:25130-25138.
13. Chang C.-H., Curtis Jonathan D., Maggi Leonard B., Faubert B., Villarino Alejandro V., O'sullivan D., Huang Stanley C.-C., van der Windt Gerritje J.W., Blagih J., Qui J., Weber Jason D., Pearce Edward J., Jones Russell G., Pearce Erika L. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 2013, 153:1239-1251.
14. Chang J.T., Wherry E.J., Goldrath A.W. Molecular regulation of effector and memory T cell differentiation. Nat. Immunol. 2014, 15:1104-1115.
15. Cheng J., Montecalvo A., Kane L.P. Regulation of NF-κB induction by TCR/CD28. Immunol. Res. 2011, 50:113-117.
16. Chua Y.L., Dufour E., Dassa E.P., Rustin P., Jacobs H.T., Taylor C.T., Hagen T. Stabilization of hypoxia-inducible factor-1α protein in hypoxia occurs independently of mitochondrial reactive oxygen species production. J. Biol. Chem. 2010, 285:31277-31284.
17. Clambey E.T., McNamee E.N., Westrich J.A., Glover L.E., Campbell E.L., Jedlicka P., Zoeten E.F.D., Cambier J.C., Stenmark K.R., Colgan S.P., Eltzschig H.K. Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E2784-E2793.
18. Cui G., Staron Matthew M., Gray Simon M., Ho P.-C., Amezquita Robert A., Wu J., Kaech Susan M. IL-7-Induced Glycerol Transport and TAG Synthesis Promotes Memory CD8+ T Cell Longevity. Cell 2015, 161:750-761.
19. Dang E.V., Barbi J., Yang H.-Y., Jinasena D., Yu H., Zheng Y., Bordman Z., Fu J., Kim Y., Yen H.-R., Luo W., Zeller K., Shimoda L., Topalian S.L., Semenza G.L., Dang C.V., Pardoll D.M., Pan F. Control of TH17/Treg balance by hypoxia-inducible factor 1. Cell 2011, 146:772-784.
20. Darce J., Rudra D., Li L., Nishio J., Cipolletta D., Rudensky A.Y., Mathis D., Benoist C. An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbate diabetes. Immunity 2012, 36:731-741.
21. Doedens A.L., Phan A.T., Stradner M.H., Fujimoto J.K., Nguyen J.V., Yang E., Johnson R.S., Goldrath A.W. Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen. Nat. Immunol. 2013, 14:1173-1182.
22. Epstein A.C.R., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.-M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., Ratcliffe P.J. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001, 107:43-54.
23. Finlay D.K., Rosenzweig E., Sinclair L.V., Feijoo-Carnero C., Hukelmann J.L., Rolf J., Panteleyev A.A., Okkenhaug K., Cantrell D.A. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J. Exp. Med. 2012, 209:2441-2453.
24. Firth J.D., Ebert B.L., Pugh C.W., Ratcliffe P.J. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:6496-6500.
25. Gubser P.M., Bantug G.R., Razik L., Fischer M., Dimeloe S., Hoenger G., Durovic B., Jauch A., Hess C. Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch. Nat. Immunol. 2013, 14:1064-1072.
26. Guzy R.D., Hoyos B., Robin E., Chen H., Liu L., Mansfield K.D., Simon M.C., Hammerling U., Schumacker P.T. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 2005, 1:401-408.
27. Heng T.S.P., Painter M.W., Elpek K., Lukacs-Kornek V., Mauermann N., Turley S.J., Koller D., Kim F.S., Wagers A.J., Asinovski N., Davis S., Fassett M., Feuerer M., Gray D.H.D., Haxhinasto S., Hill J.A., Hyatt G., Laplace C., Leatherbee K., Mathis D., Benoist C., Jianu R., Laidlaw D.H., Best J.A., Knell J., Goldrath A.W., Jarjoura J., Sun J.C., Zhu Y., Lanier L.L., Ergun A., Li Z., Collins J.J., Shinton S.A., Hardy R.R., Friedline R., Sylvia K., Kang J. The immunological genome project: networks of gene expression in immune cells. Nat. Immunol. 2008, 9:1091-1094.
28. Higashiyama M., Hokari R., Hozumi H., Kurihara C., Ueda T., Watanabe C., Tomita K., Nakamura M., Komoto S., Okada Y., Kawaguchi A., Nagao S., Suematsu M., Goda N., Miura S. HIF-1 in T cells ameliorated dextran sodium sulfate-induced murine colitis. J. Leukoc. Biol. 2012, 91:901-909.
29. Hsiao H.-W., Hsu T.-S., Liu W.-H., Hsieh W.-C., Chou T.-F., Wu Y.-J., Jiang S.-T., Lai M.-Z. Deltex1 antagonizes HIF-1α and sustains the stability of regulatory T cells in vivo. Nat. Commun. 2015, 6.
30. Ikejiri A., Nagai S., Goda N., Kurebayashi Y., Osada-Oka M., Takubo K., Suda T., Koyasu S. Dynamic regulation of Th17 differentiation by oxygen concentrations. Int. Immunol. 2012, 24:137-146.
31. Isaacs J.S., Jung Y.J., Mole D.R., Lee S., Torres-Cabala C., Chung Y.-L., Merino M., Trepel J., Zbar B., Toro J., Ratcliffe P.J., Linehan W.M., Neckers L. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 2005, 8:143-153.
32. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J.M., Lane W.S., Kaelin W.G. HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001, 292:464.
33. 2-regulated prolyl hydroxylation. Science 2001, 292:468-472.
34. Jeker L.T., Bluestone J.A. MicroRNA regulation of T-cell differentiation and function. Immunol. Rev. 2013, 253:65-81.
35. Kidani Y., Elsaesser H., Hock M.B., Vergnes L., Williams K.J., Argus J.P., Marbois B.N., Komisopoulou E., Wilson E.B., Osborne T.F., Graeber T.G., Reue K., Brooks D.G., Bensinger S.J. Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity. Nat. Immunol. 2013, 14:489-499.
36. Kim J.-w., Tchernyshyov I., Semenza G.L., Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006, 3:177-185.
37. Lando D., Peet D.J., Whelan D.A., Gorman J.J., Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science 2002, 295:858-861.
38. Lukashev D., Caldwell C., Ohta A., Chen P., Sitkovsky M. Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1α in activated T lymphocytes. J. Biol. Chem. 2001, 276:48754-48763.
39. Lukashev D., Klebanov B., Kojima H., Grinberg A., Ohta A., Berenfeld L., Wenger R.H., Ohta A., Sitkovsky M. Cutting edge: hypoxia-inducible factor 1α and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. J. Immunol. 2006, 177:4962-4965.
40. Mahon P.C., Hirota K., Semenza G.L. FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001, 15:2675-2686.
41. Makino Y., Kanopka A., Wilson W.J., Tanaka H., Poellinger L. Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3α Locus. J. Biol. Chem. 2002, 277:32405-32408.
42. Marxsen Jan H., Stengel P., Doege K., Heikkinen P., Jokilehto T., Wagner T., Jelkmann W., Jaakkola P., Metzen E. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-α-prolyl-4-hydroxylases. Biochem. J. 2004, 381:761-767.
43. Mascanfroni I.D., Takenaka M.C., Yeste A., Patel B., Wu Y., Kenison J.E., Siddiqui S., Basso A.S., Otterbein L.E., Pardoll D.M., Pan F., Priel A., Clish C.B., Robson S.C., Quintana F.J. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α. Nat. Med. 2015, advance online publication.
44. Maynard M.A., Qi H., Chung J., Lee E.H.L., Kondo Y., Hara S., Conaway R.C., Conaway J.W., Ohh M. Multiple splice variants of the human HIF-3α locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex. J. Biol. Chem. 2003, 278:11032-11040.
45. McMahon S., Charbonneau M., Grandmont S., Richard D.E., Dubois C.M. Transforming growth factor β1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J. Biol. Chem. 2006, 281:24171-24181.
46. McNamee E.N., Johnson D.K., Homann D., Clambey E.T. Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function. Immunol. Res. 2013, 55:58-70.
47. Metzen E., Stiehl Daniel P., tiehl K., Doege J., Marxsen Jan H., Hellwig-Bürgel T., Jelkmann W. Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element. Biochem. J. 2005, 387:711-717.
48. Michalek R.D., Gerriets V.A., Jacobs S.R., Macintyre A.N., MacIver N.J., Mason E.F., Sullivan S.A., Nichols A.G., Rathmell J.C. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 2011, 186:3299-3303.
49. Nakamura H., Makino Y., Okamoto K., Poellinger L., Ohnuma K., Morimoto C., Tanaka H. TCR engagement increases hypoxia-inducible factor-1α protein synthesis via Rapamycin-sensitive pathway under hypoxic conditions in human peripheral T cells. J. Immunol. 2005, 174:7592-7599.
50. O'Sullivan D., van der Windt Gerritje J.W., Huang Stanley C.-C., Curtis Jonathan D., Chang C.-H., Buck Michael D., Qiu J., Smith Amber M., Lam Wing Y., DiPlato Lisa M., Hsu F.-F., Birnbaum Morris J., Pearce Edward J., Pearce Erika L. Memory CD8+ T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity 2014, 41:75-88.
51. Oestreich K.J., Read K.A., Gilbertson S.E., Hough K.P., McDonald P.W., Krishnamoorthy V., Weinmann A.S. Bcl-6 directly represses the gene program of the glycolysis pathway. Nat. Immunol. 2014, 15:957-964.
52. Pagani M., Rossetti G., Panzeri I., de Candia P., Bonnal R.J.P., Rossi R.L., Geginat J., Abrignani S. Role of microRNAs and long-non-coding RNAs in CD4+ T-cell differentiation. Immunol. Rev. 2013, 253:82-96.
53. Palazón A., Martínez-Forero I., Teijeira A., Morales-Kastresana A., Alfaro C., Sanmamed M.F., Perez-Gracia J.L., Peñuelas I., Hervás-Stubbs S., Rouzaut A., d.Landázuri M.O., Jure-Kunkel M., Aragonés J., Melero I. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy. Cancer Discovery 2012, 2:608-623.
54. Palazon A., Goldrath Ananda W., Nizet V., Johnson Randall S. HIF transcription factors, inflammation, and immunity. Immunity 2014, 41:518-528.
55. Pang K.C., Dinger M.E., Mercer T.R., Malquori L., Grimmond S.M., Chen W., Mattick J.S. Genome-wide identification of long noncoding RNAs in CD8+ T cells. J. Immunol. 2009, 182:7738-7748.
56. Paul S., Schaefer B.C. A new look at TCR signaling to NF-κB. Trends Immunol. 2013, 34:269-281.
57. Pearce E.L., Poffenberger M.C., Chang C.-H., Jones R.G. Fueling immunity: insights into metabolism and lymphocyte function. Science 2013, 342:1242454.
58. Pescador N., Cuevas Y., Naranjo S., Alcaide M., Villar D., Manuel O.L., andazuri L., del P., eso Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem. J. 2005, 390:189-197.
59. Peyssonnaux C., Datta V., Cramer T., Doedens A., Theodorakis E.A., Gallo R.L., Hurtado-Ziola N., Nizet V., Johnson R.S. HIF-1α expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 2005, 115:1806-1815.
60. Pollizzi K.N., Powell J.D. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat. Rev. Immunol. 2014, 14:435-446.
61. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A.S., Nizet V., Johnson R.S., Haddad G.G., Karin M. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 2008, 453:807-811.
62. Schwartz R.S., Eltzschig H.K., Carmeliet P. Hypoxia and inflammation. N. Engl. J. Med. 2011, 364:656-665.
63. Selak M.A., Armour S.M., MacKenzie E.D., Boulahbel H., Watson D.G., Mansfield K.D., Pan Y., Simon M.C., Thompson C.B., Gottlieb E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 2005, 7:77-85.
64. Semenza G.L. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu. Rev. Pathol.: Mech. Dis. 2014, 9:47-71.
65. Sena Laura A., Li S., Jairaman A., Prakriya M., Ezponda T., Hildeman David A., Jonathan D.Licht H., Wang C.-R., Schumacker Paul T., Licht Jonathan D., Perlman H., Bryce Paul J., Chandel Navdeep S. Mitochondria are required for antigen-specific T cell activation through reactive Oxygen species signaling. Immunity 2013, 38:225-236.
66. Shi L.Z., Wang R., Huang G., Vogel P., Neale G., Green D.R., Chi H. HIF1α-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 2011, 208:1367-1376.
67. Sukumar M., Liu J., Ji Y., Subramanian M., Crompton J.G., Yu Z., Roychoudhuri R., Palmer D.C., Muranski P., Karoly E.D., Mohney R.P., Klebanoff C.A., Lal A., Finkel T., Restifo N.P., Gattinoni L. Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. J. Clin. Invest. 2013, 123:4479-4488.
68. Takeda N., O'Dea E.L., Doedens A., Kim J.-w, Weidemann A., Stockmann C., Asagiri M., Simon M.C., Hoffmann A., Johnson R.S. Differential activation and antagonistic function of HIF-α isoforms in macrophages are essential for NO homeostasis. Genes Dev. 2010, 24:491-501.
69. Taylor Cormac T. Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem. J. 2008, 409:19.
70. Vezys V., Penaloza-MacMaster P., Barber D.L., Ha S.-J., Konieczny B., Freeman G.J., Mittler R.S., Ahmed R. 4-1BB signaling synergizes with programmed death ligand 1 blockade to augment CD8 T cell responses during chronic viral infection. J. Immunol. 2011, 187:1634-1642.
71. Wang T., Marquardt C., Foker J. Aerobic glycolysis during lymphocyte proliferation. Nature 1976, 261:702-705.
72. Wang R., Dillon C.P., Shi L.Z., Milasta S., Carter R., Finkelstein D., McCormick L.L., Fitzgerald P., Chi H., Munger J., Green D.R. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 2011, 35:871-882.
73. Wang H., Flach H., Onizawa M., Wei L., McManus M.T., Weiss A. Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210. Nat. Immunol. 2014, 15:393-401.
74. Werth N., Beerlage C., Rosenberger C., Yazdi A.S., Edelmann M., Amr A., Bernhardt W., von Eiff C., Becker K., Schäfer A., Peschel A., Kempf V.A.J. Activation of hypoxia inducible factor 1 Is a general phenomenon in infections with human pathogens. PLoS One 2010, 5:e11576.
75. Yang F., Zhang H., Mei Y., Wu M. Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the Warburg effect. Mol. Cell 2014, 53:88-100.
76. Yin Y., Choi S.-C., Xu Z., Perry D.J., Seay H., Croker B.P., Sobel E.S., Brusko T.M., Morel L. Normalization of CD4+ T cell metabolism reverses lupus. Sci. Transl. Med. 2015, 7. 274ra218-274ra218.
77. van der Windt Gerritje J.W., Everts B., Chang C.-H., Curtis Jonathan D, Freitas Tori C, Amiel E., Pearce Edward J., Pearce Erika L. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 2012, 36:68-78.
78. van der Windt G.J.W., O'Sullivan D., Everts B., Huang S.C.-C., Buck M.D., Curtis J.D., Chang C.-H., Smith A.M., Ai T., Faubert B., Jones R.G., Pearce E.J., Pearce E.L. CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:14336-14341.